Prevnar
Description
Prevnar® (Pneumococcal 7-valent Conjugate Vaccine)
Prevnar®, is a conjugate vaccine containing capsular antigens of Streptococcus pneumoniae serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F individually conjugated to diphtheria CRM197 protein.
Prevnar® is indicated for active immunization of infants and toddlers against invasive disease caused by S. pneumoniae due to capsular serotypes included in the vaccine (4, 6B, 9V, 14, 18C, 19F, and 23F). It is also indicated for active immunization of infants and toddlers against otitis media caused by serotypes included in the vaccine
Immunisation Guideline
The routine schedule followed for the vaccine is three primary doses at 2, 4 and 6 months of age and a booster at 12-15 months of age.
Additional information
vaccine-type
Pneumococcal conjugate vaccine, 7 valent (serotypes 4, 6B, 9V, 14, 18C, 19F, and 23F)
manufacturer
Pfizer
country-of-manufacture
USA
pharmaceutical-form
Liquid
package-size
1 Dose
route-of-administration
Intramuscular
preservative
None
Contraindications
Hypersensitivity to any component of the vaccine, including diphtheria toxoid, is a contraindication to use of this vaccine.